Hypoxia Increases ATX Expression by Histone Crotonylation in a HIF-2α-Dependent Manner

Autotaxin (ATX), the key enzyme that generates lysophosphatidic acid (LPA) from lysophosphatidylcholine (LPC), is involved in tumorigenesis through the ATX-LPA axis and is regarded as a valuable target in tumor therapy. Hypoxia is a major feature of solid tumors and contributes to tumor development with striking alterations in the gene expression profile. Here, we show that hypoxia induces ATX expression in a hypoxia-inducible factor (HIF) 2α-dependent fashion in human colon cancer SW480 cells. HIF-2α is directly bound to specific hypoxia response elements (HREs) in the ATX promoter. Under hypoxic conditions, knockout or inhibition of ATX suppressed the migration of SW480 cells, which could be rescued by the addition of LPA, suggesting that the induction of ATX during hypoxia promotes cancer cell migration through the ATX-LPA axis. Further studies showed that ATX expression was induced by HIF-2α through recruiting p300/CBP, which led to crotonylation but not acetylation of histone H3 in the ATX promoter region during hypoxia. Moreover, elevation of cellular histone crotonylation levels could induce ATX expression under normoxic conditions. In conclusion, our findings reveal that ATX is induced in SW480 cells during hypoxia by histone crotonylation in a HIF-2α-dependent manner, while as a novel mechanism of ATX expression regulation, the upregulation of ATX expression by histone crotonylation is not confined to hypoxia.

[1]  V. Aidinis,et al.  Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications , 2022, Cancers.

[2]  Hwan-Woo Park,et al.  Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness , 2021, International journal of molecular sciences.

[3]  Ziqiang Wang,et al.  Histone crotonylation-centric gene regulation , 2021, Epigenetics & chromatin.

[4]  K. Harper,et al.  Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion , 2019, Cancers.

[5]  Wei Li,et al.  The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy , 2019, Expert opinion on drug discovery.

[6]  G. Reynolds,et al.  Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication. , 2017, Journal of hepatology.

[7]  Y. Hoshida,et al.  The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer , 2017, Molecular & cellular oncology.

[8]  Jin Zhang,et al.  AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma , 2017, Theranostics.

[9]  G. Mills,et al.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression , 2016, Journal of Lipid Research.

[10]  Ming Guan,et al.  Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation , 2015, PloS one.

[11]  C. Allis,et al.  Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation. , 2015, Molecular cell.

[12]  V. Aidinis,et al.  Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer. , 2015, Progress in lipid research.

[13]  Carolyn J. Brown,et al.  Hypoxia and environmental epigenetics. , 2014, High altitude medicine & biology.

[14]  S. Georas,et al.  The Autotaxin–LPA Axis Emerges as a Novel Regulator of Lymphocyte Homing and Inflammation , 2014, The Journal of Immunology.

[15]  Joel I. Perez-Perri,et al.  Epigenetics: New Questions on the Response to Hypoxia , 2011, International journal of molecular sciences.

[16]  W. Wong,et al.  Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.

[17]  U. Lendahl,et al.  Generating specificity and diversity in the transcriptional response to hypoxia , 2009, Nature Reviews Genetics.

[18]  H. Arai,et al.  Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients , 2007, Annals of clinical biochemistry.

[19]  G. Casey,et al.  Reduced expression of autotaxin predicts survival in uveal melanoma , 2007, British Journal of Ophthalmology.

[20]  K. Fukuzawa,et al.  Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. , 2007, Life sciences.

[21]  Y. Kishi,et al.  Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[22]  G. Semenza Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[23]  D. Tarin,et al.  Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. , 2002, Anticancer research.

[24]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[25]  Suk Woo Nam,et al.  Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells , 2000, Oncogene.

[26]  G. Semenza,et al.  The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. , 1998, Genomics.

[27]  Y Fujii-Kuriyama,et al.  A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Risau,et al.  HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels , 1997, Mechanisms of Development.

[29]  J. Hogenesch,et al.  Characterization of a Subset of the Basic-Helix-Loop-Helix-PAS Superfamily That Interacts with Components of the Dioxin Signaling Pathway* , 1997, The Journal of Biological Chemistry.

[30]  G. Semenza,et al.  In vivo expression of mRNAs encoding hypoxia-inducible factor 1. , 1996, Biochemical and biophysical research communications.

[31]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Krutzsch,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[33]  J. Saulnier-Blache,et al.  Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis. , 2014, Biochimie.

[34]  S. McKnight,et al.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.

[35]  Kai-Uwe Eckardt,et al.  The FASEB Journal express article 10.1096/fj.02-0445fje. Published online December 17, 2002. Widespread, hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs , 2022 .